Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193805-07-002410
Filing Date
2007-09-18
Accepted
2007-09-18 15:04:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 e602614_13g-xtlbio.txt SC 13G 19262
  Complete submission text file 0001193805-07-002410.txt   21038
Mailing Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989
Business Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989 972-8-930-4440
XTL BIOPHARMACEUTICALS LTD (Subject) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: SC 13G | Act: 34 | File No.: 005-83127 | Film No.: 071122345
SIC: 2834 Pharmaceutical Preparations

Mailing Address PERCEPTIVE ADVISORS LLC 499 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address 646-205-5340
EDELMAN JOSEPH (Filed by) CIK: 0001164426 (see all company filings)

Type: SC 13G